Startups

STRM.BIO
Develops extracellular-vesicle delivery technology for gene therapies. Its platform engineers cell-derived vesicles to carry genetic payloads to target tissues, aiming to provide alternatives to viral vectors and improve how genetic medicines reach cells in the body.

